An excuse for crushing kratom: The FDA’s undue scrutiny is unscientific – The Washington Times
Great news Kratomites! This could be the first time that a Member of Congress ( or any elected official anywhere ) has ever publicly recognized the benefits of Kratom or condemned the FDA‘s abusive and improper actions against Kratom users, sellers and importers .
“Mrs. RADEWAGEN. Mr. Speaker, I rise today to submit an article from the July 23, 2015 edition of the Washington Times entitled, An excuse for crushing kratom: The FDA’s undue scrutiny is unscientific.” stated Hon. Aumua Amata Coleman Radewagen (Congresswoman from American Samoa).
“Last year, Americans spent an estimated $374 billion on prescription drugs, up 13 percent from the year before. These drugs include OxyContin, Vicodin, Percocet and others that the federal Food and Drug Administration (FDA) approved for sale without regard to their potential for abuse.
Meanwhile, the “potential for abuse” was used for many years to block even a discussion of the possible medical benefits of cannabis. And now federal officials are using it again to attack another potential natural remedy, kratom.
Kratom (Mitragyna speciosa), which derives from a tree that grows in Thailand, Malaysia, Indonesia and Papua New Guinea, has been found to reduce pain, lessen dependence on opiates (like OxyContin), and work as a mild stimulant.” Read Article Here (Congress)